Literature DB >> 29283172

Prostate cancer: A valuable tool for prediction of repeat biopsy pathology.

Pierre Karakiewicz1, Sebastiano Nazzani1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29283172     DOI： 10.1038/nrurol.2017.216

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  9 in total

1.  A prospective randomized comparison of diagnostic efficacy between transperineal and transrectal 12-core prostate biopsy.

Authors:  A Takenaka; R Hara; T Ishimura; T Fujii; Y Jo; A Nagai; M Fujisawa
Journal:  Prostate Cancer Prostatic Dis       Date:  2007-05-29       Impact factor: 5.554

2.  Proposed Adjustments to PI-RADS Version 2 Decision Rules: Impact on Prostate Cancer Detection.

Authors:  Andrew B Rosenkrantz; James S Babb; Samir S Taneja; Justin M Ream
Journal:  Radiology       Date:  2016-10-26       Impact factor: 11.105

3.  Magnetic resonance imaging detected prostate evasive anterior tumours: Further insights.

Authors:  Ghazi Al Edwan; Sangeet Ghai; David Margel; Girish Kulkarni; Rob Hamilton; Ants Toi; Masoom A Haidar; Antonio Finelli; Neil E Fleshner
Journal:  Can Urol Assoc J       Date:  2015 May-Jun       Impact factor: 1.862

4.  Positive predictive value of prostate biopsy indicated by prostate-specific-antigen-based prostate cancer screening: trends over time in a European randomized trial*.

Authors:  Leonard P Bokhorst; Xiaoye Zhu; Meelan Bul; Chris H Bangma; Fritz H Schröder; Monique J Roobol
Journal:  BJU Int       Date:  2012-10-08       Impact factor: 5.588

5.  Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy.

Authors:  Jean-Louis Campos-Fernandes; Laurence Bastien; Nathalie Nicolaiew; Grégoire Robert; Stéphane Terry; Francis Vacherot; Laurent Salomon; Yves Allory; Dimitri Vordos; Andras Hoznek; René Yiou; Jean Jacques Patard; Claude Clément Abbou; Alexandre de la Taille
Journal:  Eur Urol       Date:  2008-06-23       Impact factor: 20.096

6.  Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: a prospective study.

Authors:  James E Thompson; Daniel Moses; Ron Shnier; Phillip Brenner; Warick Delprado; Lee Ponsky; Marley Pulbrook; Maret Böhm; Anne-Maree Haynes; Andrew Hayen; Phillip D Stricker
Journal:  J Urol       Date:  2014-02-08       Impact factor: 7.450

7.  mp-MRI Prostate Characterised PIRADS 3 Lesions are Associated with a Low Risk of Clinically Significant Prostate Cancer - A Retrospective Review of 92 Biopsied PIRADS 3 Lesions.

Authors:  Heath Liddell; Rajeev Jyoti; Hodo Z Haxhimolla
Journal:  Curr Urol       Date:  2015-07-10

8.  Multi-institutional nomogram predicting benign prostate pathology on magnetic resonance/ultrasound fusion biopsy in men with a prior negative 12-core systematic biopsy.

Authors:  Matthew Truong; Bokai Wang; Jennifer B Gordetsky; Jeffrey W Nix; Thomas P Frye; Edward M Messing; John V Thomas; Changyong Feng; Soroush Rais-Bahrami
Journal:  Cancer       Date:  2017-10-04       Impact factor: 6.860

9.  Results of Targeted Biopsy in Men with Magnetic Resonance Imaging Lesions Classified Equivocal, Likely or Highly Likely to Be Clinically Significant Prostate Cancer.

Authors:  Wulphert Venderink; Annemarijke van Luijtelaar; Joyce G R Bomers; Marloes van der Leest; Christina Hulsbergen-van de Kaa; Jelle O Barentsz; J P Michiel Sedelaar; Jurgen J Fütterer
Journal:  Eur Urol       Date:  2017-02-28       Impact factor: 20.096
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.